Core Peptides describes itself as a United States chemical supplier for laboratory, research, and analytical use. Its public product pages show size-specific prices and certificate-of-analysis tabs, while its company page claims US synthesis, purity above 99%, and free delivery on orders over $200. Peptide Local records those statements as seller claims.
This seven-provider pilot measures public evidence access within a pre-existing price-tracking sample. It is not a market-wide ranking and does not establish identity, purity, quantity, sterility, safety, legality, regulatory approval, or fitness for use.
The record remains public so readers can audit the earlier score and its limits. Badge issuance is paused until a provider clears the broader independent-testing and market-qualification gate.
Submit a sourced provider correction →Every finding now carries its own public source routes. The status describes evidence completeness within the category, not a product, provider, medical, legal, or safety verdict.
Compared product pages expose a certificate-of-analysis tab; some catalog pages also expose separate HPLC or mass-spectrometry tabs.
Public, product-linked, and lot-aware routes receive more credit than request-only or general testing claims.Seller claims US synthesis, purity above 99%, and quality-control testing; page-level document access varies by compound.
Named laboratories and methods receive more credit. Seller statements remain claims unless independently established.Compared product pages expose certificate tabs and some separate analytical tabs. Public document access and lot matching vary by compound.
Direct lot matching and current report routes receive more credit than catalog-wide or undated documents.The site publishes a United States chemical-supplier identity and laboratory, research, and analytical-use scope. This assessment does not establish licensing or regulatory status.
This checks published identity and scope, not licensing, ownership, incorporation, or regulatory approval.Free shipping above $200 claimed; the below-threshold rate is not stated on the public company page.
Complete public rates and conditions receive more credit than threshold-only or checkout-only information.REVIEWS.io shows 5 visible reviews, a thin sample, and very low editorial confidence. Sentiment does not affect this score.
The score reflects sample depth and source confidence, never positive sentiment, health outcomes, or product quality claims.No provider correction exchange is included in the inaugural baseline.
The inaugural baseline awards no points until a dated provider exchange is documented. Paying, linking, or partnering cannot add points.The five-review sample is mixed and discusses fulfillment, communication, payment friction, and domain confusion.
Inspect REVIEWS.io source ↗A provider response must identify the exact disputed field and supply a current public source. Private assurances cannot replace a public record.